Effect of cyclosporine oral myocardial injury in patients undergoing coronary artery bypass surgery hospital in Ahvaz Golestan second half of 2017: a randomized controlled clinical trial
Not Applicable
- Conditions
- Myocardial heart.Myocardial degeneration
- Registration Number
- IRCT2017031533056N2
- Lead Sponsor
- Vice Chancellor for Research and Technology Development Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- All patients who undergoing coronary artery bypass surgery .
- Patients over 18 years
- willingness to participate in the study
Exclusion criteria
- patients over 85 years
- patients with unstable angina
- Patients with moderate to severe renal impairment (glomerular filtration rate less than mL / min / m2 45)
- developing cirrhosis of the liver
- Oral administration of drugs glibenclamide or nicorandil (due to drug interactions).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Troponin_I. Timepoint: Troponin I measurements before surgery and at 24hr, 48hr and 72hr after surgery. Method of measurement: After preparing the evaluation kit little troponin (cTnI) by Golestan hospital laboratory.
- Secondary Outcome Measures
Name Time Method CKMB. Timepoint: CKMB measurements before surgery and at 24hr, 48hr and 72hr after surgery. Method of measurement: CKMB measurements in the laboratory Golestan Hospital.